Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00898222 · ClinicalTrials.gov registry record · NA
Effect of Daily Low Dose Aspirin on Exhaled Inflammatory Mediators in Normal Subjects
A NA study, sponsored by Brigham and Women's Hospital.
- Completed
- Registry status
- NA
- Development phase
- 4
- Enrollment target
NCT00898222: Completed NA study, sponsored by Brigham and Women's Hospital.
NCT00898222 is a NA study that has completed, run by Brigham and Women's Hospital. The registered enrollment target is 4 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00898222, a NA study, has completed, sponsored by Brigham and Women's Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 4 participants
- Enrollment target
Study Summary
Hypothesis: Low dose aspirin does not change exhaled inflammatory breath mediators in normal subjects.
Primary Outcome
Descriptive statistics
Interventions
- DRUG aspirin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2009-05 |
| Est. Completion | 2009-08 |
| Phase | NA |
What the finished NCT00898222 record still lists
NCT00898222 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 4 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 1 intervention - of which aspirin is the first listed.
NCT00898222 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00898222 about?
NCT00898222 is a clinical study titled "Effect of Daily Low Dose Aspirin on Exhaled Inflammatory Mediators in Normal Subjects". Hypothesis: Low dose aspirin does not change exhaled inflammatory breath mediators in normal subjects.
What is the current status of trial NCT00898222?
This trial is currently completed. It is a NA study. The enrollment target is 4 participants. The study started on 2009-05. Estimated completion is 2009-08.
What interventions are being tested in trial NCT00898222?
The interventions under investigation include: aspirin (DRUG).
Who is sponsoring clinical trial NCT00898222?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00898222's enrollment target sits among peer trials
4 1996th of 2000 higher than 5 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia